Glutamate carboxypeptidase II
Glutamate carboxypeptidase II (GCPII), also known as prostate-specific membrane antigen (PSMA), is an enzyme that in humans is encoded by the FOLH1 gene. This enzyme is a type II transmembrane glycoprotein and is involved in the hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) to N-acetylaspartate (NAA) and glutamate.
Function[edit | edit source]
Glutamate carboxypeptidase II plays a crucial role in the central nervous system by regulating the levels of the neurotransmitter glutamate. Glutamate is an important excitatory neurotransmitter, and its dysregulation is associated with various neurological disorders, including Alzheimer's disease, schizophrenia, and epilepsy. GCPII is also expressed in the prostate gland, where it is referred to as prostate-specific membrane antigen (PSMA). PSMA is a marker for prostate cancer and is used in diagnostic imaging and targeted therapy.
Structure[edit | edit source]
GCPII is a zinc-dependent metallopeptidase and belongs to the M28 family of peptidases. The enzyme consists of a large extracellular domain, a single transmembrane domain, and a short intracellular tail. The extracellular domain contains the active site, which binds to zinc ions essential for its enzymatic activity.
Clinical Significance[edit | edit source]
GCPII is a target for the diagnosis and treatment of prostate cancer. PSMA expression is significantly upregulated in prostate cancer cells compared to normal prostate tissue, making it a valuable biomarker. Radiolabeled PSMA inhibitors are used in positron emission tomography (PET) imaging to detect prostate cancer metastases. Additionally, PSMA-targeted therapies, such as PSMA-targeted radioligand therapy, are being developed to treat advanced prostate cancer.
Research[edit | edit source]
Research on GCPII is ongoing to better understand its role in neurological disorders and to develop new therapeutic strategies. Inhibitors of GCPII are being investigated for their potential to modulate glutamate levels in the brain and treat conditions like neuropathic pain and cognitive disorders.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This enzyme-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
